Fundraising Fox

Ruben Osnabrugge

Investor

Partner and Chief Medical Officer at 415 Capital

Greater Munich Metropolitan Area

About

Ruben Osnabrugge, MD PhD, is Partner and Chief Medical Officer at 415 Capital, where he combines clinical expertise with investment work in cardiovascular and medtech technologies. He trained in cardiothoracic surgery and holds a PhD in cardiovascular medicine, and focuses on evaluating and translating novel interventional therapies and medical devices into clinical practice. His investment responsibilities include clinical due diligence, strategic evaluation, and ongoing portfolio engagement.

Contact· self-published, not guessed

Invests in

BiotechDigital HealthMedical Devices

Experience

  1. 415 CapitalPartnercurrent2023 — presentMunich, Bavaria, Germany
  2. Endovascular EngineeringMember Board of Directorscurrent2025 — presentMenlo Park, California, United States
  3. TRiCares GmbHBoard Observercurrent2024 — presentGreater Munich Metropolitan Area
  4. Cardiac Success Ltd.Member Board of Directorscurrent2023 — presentYokneam Ilit, North District, Israel
  5. Erasmus MCPostdoctoral Researcher Thoraxcentercurrent2015 — presentRotterdam, South Holland, Netherlands
  6. Erasmus MCMD Cardiothoracic surgery2016 — 2019
  7. Erasmus MCPhD fellow at the Dept. of Cardio-Thoracic Surgery2012 — 2015Rotterdam, South Holland, Netherlands
  8. Erasmus MCResearcher at Depts. of Cardio-Thoracic Surgery and Epidemiology2010 — 2012The Randstad, Netherlands
  9. Erasmus MCUniversity Council2010 — 2011
  10. Erasmus MCEducation Committee2008 — 2010
  11. EQT Life SciencesDirector / Investment Manager2021 — 2023Amsterdam, Munich, Boston
  12. XeltisBoard Observer2022 — 2023Eindhoven Area
  13. FundamentalVRBoard Observer2022 — 2023Greater London, England, United Kingdom
  14. LumavisionBoard Observer2022 — 2023Dublin, County Dublin, Ireland
  15. LSPAssociate2021 — 2022Amsterdam, Munich, Boston
  16. PhilipsGlobal Strategic Program Lead Value Based Care2019 — 2021The Randstad, Netherlands
  17. MedTech EuropeRepresentative2020 — 2021Brussels, Brussels Region, Belgium
  18. PCRFaculty2015 — 2021Greater Paris Metropolitan Region
  19. CTSNet / Cardiothoracic Surgeons NetworkEditor Journal and News Scan2013 — 2021Chicago, Illinois, United States
  20. European Association of Cardiothoracic SurgeryFaculty Member2013 — 2021Windsor, United Kingdom
  21. Franciscus Gasthuis & VlietlandGeneral Surgery Resident2018 — 2019Rotterdam, South Holland, Netherlands
  22. Eurointervention JournalAssociate Editor2013 — 2016The Randstad, Netherlands
  23. Saint Luke's Health SystemPHD Researcher2013 — 2014Kansas City Metropolitan Area

Skills & more

MedtechCardiovascular MedicineBoard GovernanceEpidemiology11Medicine6Surgery5Health Economics4Research2Healthcare14Clinical Research13Statistics2Public Health4
+12 moreEconomicsData AnalysisTeachingScienceTreeAgeLifesciencesClinical TrialsMedical EducationDutchEnglishArtsenPatiëntenzorg

From Ruben's professional profile.

Colleagues at 415 Capital

Frequently asked questions

Who is Ruben Osnabrugge?
Ruben Osnabrugge, MD PhD, is Partner and Chief Medical Officer at 415 Capital, where he combines clinical expertise with investment work in cardiovascular and medtech technologies. He trained in cardiothoracic surgery and holds a PhD in cardiovascular medicine, and focuses on evaluating and translating novel interventional therapies and medical devices into clinical practice. His investment responsibilities include clinical due diligence, strategic evaluation, and ongoing portfolio engagement.
Where does Ruben Osnabrugge work?
Ruben Osnabrugge is Partner and Chief Medical Officer at 415 Capital.
What does Ruben Osnabrugge invest in?
Ruben Osnabrugge invests in Biotech, Digital Health, Medical Devices.
Where did Ruben Osnabrugge go to school?
Ruben Osnabrugge studied at Erasmus University Rotterdam (MD, Medicine); Netherlands Institute for Health Sciences (NIHES) (MSc, Health Sciences-Clinical Epidemiology); Harvard T.H. Chan School of Public Health.

Same school

Shared employers